Mental Stress Reactivity in Women With Coronary Microvascular Dysfunction
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 150
- 试验地点
- 4
- 主要终点
- Changes in HRV with mental stress
研究概览
简要总结
Coronary Microvascular Dysfunction (CMD) occurs when there are problems in the small blood vessels/arteries of the heart, resulting in persistent chest pain that affects women.
There are an estimated 3 million women in the US with CMD and about 100,000 new cases annually. This research will investigate whether the stress response physiology and autonomic function in response to mental stress are different in women with CMD compared to other groups. The autonomic nervous system (ANS) controls normally involuntary activities, such as heart rate, respiration (breathing), body temperature, blood pressure, and urinary function. This study will also examine how chronic and daily life mental stress affects the heart and blood vessels.
Participants from this study will be recruited mainly from Emory Healthcare-associated hospitals, the Emory Heart Disease Center for Prevention, and Emory Healthcare outpatient cardiology clinics. Participants will have physical exams, blood tests, stress tests, exercise tests, surveys, questionnaires, and images taken of their hearts and blood vessels. They will be asked to take home devices to monitor their autonomic function, sleep, and track their mood, stress level, and symptoms for one week. Data and specimens will be saved for future research.
详细描述
The overall goal of this project is to clarify the mechanisms and pathophysiology of how psychological stress contributes to Major Adverse Cardiovascular Events (MACE) in women despite having no obstructive CAD. Through this proposal, the research team expects to have an improved understanding of the relationships between mental stress and coronary microvascular dysfunction in women.
One-third to one-half of women with chest pain who are suspected of having myocardial ischemia and undergo coronary angiography are actually found to have no obstructive coronary artery disease (CAD) (<50% luminal stenosis) and thus are often reassured and dismissed without a cardiac diagnosis or therapy. Current evidence suggests that a large proportion of these women have coronary microvascular dysfunction (CMD) and are at significantly increased risk of major adverse cardiovascular events (MACE), including myocardial infarction, heart failure, and sudden cardiac death. However, because of substantial knowledge gaps, these patients also have recurrent hospitalizations for chest pain, reduced health-related quality of life, and comparable disability and healthcare costs to obstructive CAD patients. Cardiac rest/stress positron emission tomography (PET) imaging can detect impaired myocardial flow reserve (MFR) and diagnose CMD. However, therapeutic strategies are poorly developed, with limited studies to inform clinicians on the treatment of CMD.
Comorbid psychological factors such as anxiety and depression are prevalent in women with persistent angina, and stress can contribute to and exacerbate angina, implicating the autonomic nervous system (ANS) as one mechanistic pathway in CMD-related ischemia and MACE. The preliminary data indicate that women with CMD have ANS dysfunction with sympathetic predominance compared to non-CMD controls. The research team has shown that women have more mental stress ischemia (MSI) and stress-induced peripheral microvascular vasoconstriction compared to men. MSI is an important prognostic marker with an estimated two-fold increase in MACE, including mortality, regardless of the severity of CAD.
The research team posits that an improved understanding of psychological stress reactivity in CMD patients will help tease out the underlying mechanisms contributing to adverse outcomes in CMD-related ischemia and provide new treatment targets to reduce symptom burden and MACE. The overall goal of this project is to clarify the mechanisms and pathophysiology of how psychological stress contributes to MACE in women despite having no obstructive CAD. The research team has also shown that coronary microvascular responses to mental stress are reflected in the peripheral microvascular circulation. This proposal addresses an important knowledge gap in an understudied population and is a direct extension of their prior work. Findings from this work have the potential to inform therapeutic strategies in CMD, a problem that impacts an estimated 3 million American women. The unifying hypothesis is that women with CMD have exaggerated sympathetic activation and abnormal vasoreactivity to mental stress, which predisposes them to adverse outcomes even in the absence of obstructive CAD.
Three groups of post-menopausal women will be compared: (1) symptomatic women with no obstructive CAD who have CMD ; (2) symptomatic women with chronic obstructive CAD (oCAD); and (3) asymptomatic control women with no prior history of CAD or angina, who are age-matched to the CMD women. The oCAD group will serve as a comparison group since these women represent the prevailing paradigm of ischemia from obstructive stenosis while sharing common cardiovascular risk factors that could confound the findings.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Screening
- 盲法
- None
入排标准
- 年龄范围
- 45 Years 至 —(Adult, Older Adult)
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Inclusion Criteria:
- •Symptomatic postmenopausal women with chest pain
- •age≥45 years old
- •willing to undergo cardiac MIBG scan
- •willing to undergo mental stress testing
- •competent to give informed consent
排除标准
- •Significant epicardial stenosis (defined by coronary stenosis ≥ 70% in any epicardial coronary artery or hemodynamically significant stenosis determined by fractional flow reserve)
- •Left ventricular systolic dysfunction (ejection fraction ≤ 50%)
- •Heart failure with a preserved ejection fraction
- •Significant anemia or blood dyscrasia
- •Severe uncontrolled hypertension >180/100
- •Unable to lie flat for mental stress testing
- •Pre-menopausal
- •Pericarditis/myocarditis
- •History of percutaneous coronary intervention
- •Coronary artery bypass grafting
- •Acute myocardial infarction/acute coronary syndrome/unstable angina within 1 month
- •Significant valvular disease, including aortic or mitral stenosis
- •Sinus node dysfunction/pacemaker, 2nd or 3rd-degree atrioventricular block
- •Severe lung, renal, liver, or psychiatric illness
- •Current neoplasm
- •History of substance abuse
- •Acute illness such as infection in the previous 4 weeks
- •Life-expectancy less than 2 years
- •Unable to safely withdraw medications for mental stress testing
- •Significant psychiatric illness that precludes safe participation in the study
- •Conditions that preclude accurate or safe testing and patient refusal
- •Unable to consent
- •Obstructive CAD (oCAD) Group
- •Inclusion Criteria:
- •Symptomatic postmenopausal women with chest pain who have obstructive CAD in at least one epicardial coronary artery
- •willing to undergo cardiac MIBG scan
- •willing to undergo mental stress testing
- •competent to give informed consent
- •Exclusion Criteria:
- •Significant epicardial stenosis (defined by coronary stenosis ≥ 70% in any epicardial coronary artery or hemodynamically significant stenosis determined by fractional flow reserve)
- •Left ventricular systolic dysfunction (ejection fraction ≤ 50%)
- •Heart failure with a preserved ejection fraction
- •Significant anemia or blood dyscrasia
- •Severe uncontrolled hypertension >180/100
- •Unable to lie flat for mental stress testing
- •Pre-menopausal
- •Pericarditis/myocarditis
- •History of percutaneous coronary intervention
- •Coronary artery bypass grafting
- •Acute myocardial infarction/acute coronary syndrome/unstable angina within 1 month
- •Significant valvular disease, including aortic or mitral stenosis
- •Sinus node dysfunction/pacemaker, 2nd or 3rd-degree atrioventricular block
- •Severe lung, renal, liver, or psychiatric illness
- •Current neoplasm
- •History of substance abuse
- •Acute illness such as infection in the previous 4 weeks
- •Life expectancy is less than 2 years
- •Unable to safely withdraw medications for mental stress testing
- •Significant psychiatric illness that precludes safe participation in the study
- •Conditions that preclude accurate or safe testing and patient refusal
- 另有 38 项未显示
研究组 & 干预措施
Symptomatic women with no obstructive CAD who have CMD
Symptomatic women with chest pain and no obstructive CAD who have an abnormal myocardial flow reserve (MFR < 2.5)
干预措施: Study Procedures (Other)
Symptomatic women with chronic obstructive CAD (oCAD)
This group will serve as one comparison group since these women represent the prevailing paradigm of ischemia from obstructive stenosis while sharing common cardiovascular risk factors with the CMD group.
干预措施: Study Procedures (Other)
Asymptomatic control women with no prior history of CAD or angina
Asymptomatic control women with no prior history of CAD or angina, who are age-matched to the CMD women; not on any cardiac medications, who will also have to pass a maximal Bruce protocol exercise treadmill test.
干预措施: Study Procedures (Other)
结局指标
主要结局
Changes in HRV with mental stress
时间窗: Baseline (prior to stress testing) and during mental stress test
The research team will also compare autonomic reactivity during a standardized mental stress test, including heart rate variability (HRV) between CMD women and the two control groups
Changes in pre-ejection period (PEP) with mental stress
时间窗: Baseline (prior to stress testing) and during mental stress test
The research team will also compare autonomic reactivity during a standardized mental stress test, including the pre-ejection period (PEP) between CMD women and the two control groups. This measures systolic time interval and reflects cardiac contractility (which is under the beta-adrenergic influence). Impedance ECG measures PEP from the onset of ventricular depolarization (Q-wave on ECG) to the opening of the aortic valve for ejection of blood from the left ventricle.
Planar late Heart to Mediastinal Ratio (MIBG imaging)
时间窗: At the end of MIBG procedure
The research team will compare resting sympathetic activity measured with 123I-meta-iodobenzylguanidine (MIBG) imaging between CMD women and the two control groups. The heart to the mediastinal ratio (HMR) which is an index of MIBG uptake will be calculated as per standard methods. The HMR reflects norepinephrine kinetics. Higher sympathetic activity and turnover cause less MIBG to be retained and result in a lower HMR. MIBG SPECT defect score will be determined by late (4 hours) MIBG uptake by visual blind scoring using the standard 17-segment model with 0=normal tracer uptake, 1=mildly reduced uptake, 2=moderately reduced uptake, 3=severely reduced uptake, 4=absent tracer uptake, as defined by Bax et al.
次要结局
- Changes in flow mediated dilation (FMD test) to acute mental stress in CMD women.(Baseline (prior to stress testing) and at the end of the mental stress test)
- Examine whether chronic stress burden and autonomic dysfunction during daily life is elevated in CMD women.(At the end of 1 week of monitoring)
- Changes in Peripheral arterial tonometry (PAT) test to acute mental stress in CMD women.(Baseline (prior to stress testing) and at the end of the mental stress test)
研究者
Puja Mehta
Associate Professor
Emory University
